ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-32852

MailEnable versions prior to 10.55 contain a reflected cross-site scripting vulnerability in the webmail interface that allows remote attackers to execute arbitrary Ja…

Published Mar 23, 2026 · catalog updated Jun 17, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-32852. EPSS is 0.46%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.46%
Remediation
Advisory link
Affected products
cpe mailenable/mailenable

MailEnable versions prior to 10.55 contain a reflected cross-site scripting vulnerability in the webmail interface that allows remote attackers to execute arbitrary JavaScript in a victim's browser by crafting a malicious URL. Attackers can inject malicious code through the StartDate parameter in the FreeBusy.aspx form, which is not properly sanitized before being embedded into dynamically generated JavaScript.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe mailenable/mailenableversion unspecified

How to fix CVE-2026-32852

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-32852. EPSS is 0.46%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.46%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 23, 2026 · NIST NVD

    Detected

    MailEnable versions prior to 10.55 contain a reflected cross-site scripting vulnerability in the webmail interface that allows remote attackers to execute arbitrary JavaScript in a victim's browser by crafting a malicious URL. Attackers can inject malicious code through the StartDate parameter in the FreeBusy.aspx form, which is not properly sanitized before being embedded into dynamically generat

  2. Jun 17, 2026 · NIST NVD

    Updated

    MailEnable versions prior to 10.55 contain a reflected cross-site scripting vulnerability in the webmail interface that allows remote attackers to execute arbitrary JavaScript in a victim's browser by crafting a malicious URL. Attackers can inject malicious code through the StartDate parameter in the FreeBusy.aspx form, which is not properly sanitized before being embedded into dynamically generat

Sources

  • CVE.orgVulnerability recordCVE-2026-32852

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-32852

    30-day exploitation probability 0.5%

    first.org
  • NIST NVDVulnerability recordCVE-2026-32852

    MailEnable versions prior to 10.55 contain a reflected cross-site scripting vulnerability in the webmail interface that allows remote attackers to execute arbitrary JavaScript in a victim's browser by crafting a malicious URL. Attackers can inject malicious code through the Start

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.